Clear. 73.8   F New York
AI-Powered News Summarizer
Top Stories

India records more than 100,000 new Covid-19 cases -- its most in a single day since the pandemic began

April 5, 2021. Summarized by summa-bot.

Compression ratio: 74%. 2 min read.

NEW DELHI, INDIA - APRIL 3: A health worker in PPE coveralls collects a swab sample from a traveller for Covid-19 testing at Anand Vihar Bus Terminal (ISBT), on April 3, 2021 in New Delhi, India. (Photo by Sanchit Khanna/Hindustan Times via Getty Images)

India recorded 103,558 new Covid-19 cases on Monday, its highest single-day rise in infections so far in the pandemic.

India recorded 103,558 new Covid-19 cases on Monday, its highest single-day rise in infections so far in the pandemic.

The number of new daily cases in India has risen steadily since March 10, with the country also reporting 741,830 active cases on Monday -- its most since October 20.

As of Monday, India has recorded 12,589,067 cases of coronavirus, the third-highest in the world, including 165,101 related deaths and 11,682,136 recoveries.

The federal government has moved to stop any further risk of contamination at a Baltimore contract vaccine manufacturer where 15 million potential doses of Johnson & Johnson vaccine were spoiled last month, telling rival drugmaker AstraZeneca it must move its production from the plant and find somewhere else to make its vaccine.

The Emergent BioSolutions plant in Baltimore was making coronavirus vaccines under contract to both Johnson & Johnson and AstraZeneca.

Last month, a batch of Johnson & Johnson "drug product" failed quality control and was taken out of production, both J&J and Emergent have said.

The federal government has directed Johnson & Johnson to fully take over its vaccine production at the plant, an administration official told CNN Saturday.

The Emergent BioSolutions plant, which had been making doses of both Johnson & Johnson's vaccine as well as a vaccine made for AstraZeneca, will now only produce J&J vaccines, the official said.

The Health and Human Services Department has directed that the AstraZeneca vaccine will now be produced at another plant, although the official did not specify where.

"Johnson & Johnson is assuming full responsibility regarding the manufacturing of drug substance for its COVID-19 vaccine at the Emergent BioSolutions Inc. Bayview facility," the company said in a statement emailed to CNN.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.